Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study
Katie Paul-Friedman
Russell Thomas
10.23645/epacomptox.6879635.v1
https://epa.figshare.com/articles/presentation/Examining_the_Utility_of_In_Vitro_Bioactivity_as_a_Conservative_Point_of_Departure_A_Case_Study/6879635
Presentation at RIVM (Netherlands National Institute for Public Health and the Environment) visit to EPA April 2018
2018-07-30 19:42:49
bioactivity data
high-throughput toxicokinetics
ToxCast
point of departure
Toxicology